Ken Solovay, Chief Operating Officer. He has 25 years experience in the healthcare industry, including positions in product development and program management at Johnson & Johnson and C.R. Bard as well as executive management roles at the start-up ventures Aspiration Medical Technology (AMT), GMP Companies and Seedlings Life Science Ventures. As President of AMT, Ken was responsible for bringing an obesity treatment from concept through development and validation in clinical trials, as well as being instrumental in the company completing a $16 million series D capital fundraise that led ultimately to FDA PMA approval. Ken has extensive experience developing implantable devices with minimally invasive delivery systems, and holds 35 US patents. Ken has a M.S. in Biomedical Engineering from the University of Alabama at Birmingham with an expertise in Biomaterials, and a B.S. in Materials Science & Engineering from the University of Florida.